Parkinson disease study now enrolling hase 2b study evaluating CERE-120
Parkinson disease study now enrolling
http://www.bcm.edu/news/item.cfm?newsID=2997 RSS icon HOUSTON -- (November 2, 2010) -- Enrollment has begun in a new double-blind Phase 2b study evaluating CERE-120 in Parkinson's disease patients. Baylor College of Medicine is one of eight clinical sites enrolling along with 11 major medical centers across the country. CERE-120 is a gene therapy product that delivers the neurotrophic factor neurturin to degenerating or dying dopamine neurons in the hopes it will restore function and protect brain cells from further damage. More Information: PDtrials.org Clinical Trials.gov Following is a List of Participating Sites: Alabama University of Alabama, Birmingham Rebecca McMurray rmcmurr@uab.edu Phone: (205) 996-4034 Birmingham, AL USA California Stanford School of Medicine Maria Coburn mcoburn@stanford.edu Phone: (650) 723-5575 Palo Alto, CA USA University of California, San Francisco Robin Taylor robin.taylor@ucsf.edu Phone: (415) 353-1555 San Francisco, CA USA Georgia Emory University Hospital Mary Louise Weeks mmusant@emory.edu Phone: (404) 728-4982 Atlanta, GA USA Illinois Rush University Medical Center Jeana Jaglin Jean_A_Jaglin@rush.edu Phone: (312) 563-2900 Chicago, IL USA North Carolina Duke University Lisa Gauger lisa.gauger@duke.edu Phone: (919) 668-1538 Durham, NC USA New York Columbia University Medical Center Linda Winfield lmw4@mail.cumc.columbia.edu Phone: (212) 305-0549 New York, NY USA Mt. Sinai Medical Center Ricardo Renvill ricardo.renvill@mssm.edu Phone: (212) 461-4633 New York, NY USA Beth Israel Medical Center Rabhi Kashouty rkashouty@chpnet.org Phone: (212) 844-6571 New York, NY USA Pennsylvania University of Pennsylvania Heather Maccarone heather.maccarone@pahosp.com Phone: (215) 829-7181 Philadelphia, PA USA Texas Primary Contact at Ceregene Ceregene, Inc. Joao Siffert, M.D. — Chief Medical Officer jsiffert@ceregene.com Phone: (858) 458-8890 |
All times are GMT -5. The time now is 08:07 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.